Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more
Head-to-head evidence comparison — which supplement is right for you?
Probiotics wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
0 of 1 studies with measurable effects showed benefit.
Top outcomes
Verdict
Probably helps
18 of 26 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Holy Basil and Probiotics have evidence — compare verdict strength side-by-side.
300-600mg extract (2.5% ursolic acid)
Morning, With or without food
Standardized extract (leaf)
10-20 billion CFU
With or without food (strain-dependent), Same time daily for consistency
Capsules with multiple strains
2-4 weeks
2-4 weeks
4-8 weeks
2-4 weeks
4-8 weeks
4-8 weeks
First 1-2 weeks
The Neuroprotective Potential of Ocimum Plant Species: Seasoning the Mind with Sweet and Holy Basil
Nutrients (2025) · Systematic review
This review synthesizes experimental evidence regarding Ocimum species with neuroprotective potential in AD, particularly Ocimum sanctum and Ocimum basilicum.
Modulation of the hypothalamic-pituitary-adrenal (HPA) axis by plants and phytonutrients: a systematic review of human trials
Nutritional neuroscience (2022) · Systematic review
For most phytonutrients, the effects of supplementation on HPA-axis activity in humans is unclear.
Medicinal Plants in the Treatment of Respiratory Diseases and their Future Aspects
Recent patents on biotechnology (2025) · Systematic review
Some medicinal plants, notably Echinacea purpurea and Zingiber officinale, exhibit potential for adjuvant symptomatic therapy in respiratory conditions, such as chronic obstructive pulmonary disease (COPD), bronchitis, asthma, the common cold, cough, and whooping cough.
Preventive Effect of Probiotics on Oral Mucositis Induced by Cancer Treatment: A Systematic Review and Meta-Analysis
International journal of molecular sciences (2022) · Meta analysis · n=708
Three trials using Lactobacilli-based probiotics reported that the incidence of oral mucositis in the probiotic group was significantly low (risk ratio [RR] = 0.84, 95% confidence interval [CI] = 0.77−0.93, p = 0.0004).
Probiotics for treating acute infectious diarrhoea
The Cochrane database of systematic reviews (2020) · Meta analysis · n=12127
Effect size was similar in the sensitivity analysis and marked heterogeneity persisted.
Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children
The Cochrane database of systematic reviews (2017) · Meta analysis · n=9955
A complete case analysis (i.e. participants who completed the study) among trials investigating CDAD (31 trials, 8672 participants) suggests that probiotics reduce the risk of CDAD by 60%.
Based on systematic review evidence of HPA-axis modulation and adaptogenic properties. However, reviewers note that effects on HPA-axis activity in humans remain unclear and require more definitive research. Conservative estimates due to limited human trial data.
Based on meta-analyses showing benefits for IBS and digestive symptoms. Effect sizes varied considerably between studies with low to very low certainty of evidence. Initial GI symptoms common when starting but typically resolve within 1-2 weeks.
AI-estimated from published studies. Interpret as directional guidance.
Probiotics has a higher evidence score (9/10 vs 8.5/10) and wins in 2 of 3 categories.
For reduce inflammation, Probiotics has a higher relevance score (95 vs 65).
No known interactions between Holy Basil and Probiotics have been documented in our database. However, always consult a healthcare provider before combining supplements.